CY1120610T1 - NEW COMPOSITION FOR THE EXTRAORDINARY REDUCTION OF BETA-AMYLOIDS AND ITS PRODUCTION PROCESS - Google Patents
NEW COMPOSITION FOR THE EXTRAORDINARY REDUCTION OF BETA-AMYLOIDS AND ITS PRODUCTION PROCESSInfo
- Publication number
- CY1120610T1 CY1120610T1 CY181100895T CY181100895T CY1120610T1 CY 1120610 T1 CY1120610 T1 CY 1120610T1 CY 181100895 T CY181100895 T CY 181100895T CY 181100895 T CY181100895 T CY 181100895T CY 1120610 T1 CY1120610 T1 CY 1120610T1
- Authority
- CY
- Cyprus
- Prior art keywords
- beta
- amyloids
- subject
- dialysis
- composition
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μια ασφαλή, αξιόπιστη και οικονομική διαδικασία για την παρασκευή ενός βελτιωμένου παρασκευάσματος υγρού διαπίδυσης, το οποίο είναι αποτελεσματικό για εξωσωματική αγωγή, μέσω μιας μεθόδου διήθησης αίματος, μιας πάθησης που συνδέεται με Βήτα-Αμυλοειδές σε ένα υποκείμενο, η οποία μέθοδος περιλαμβάνει την παρασκευή μιας σύνθεσης που περιλαμβάνει ένα πεπτίδιο KLVFF ή μια παραλλαγή αυτού ως παράγοντα σύλληψης και πρόσδεσης και έναν φορέα, και την ανάμειξη της εν λόγω σύνθεσης με ένα διάλυμα αιμοκάθαρσης. Η μέθοδος χρησιμοποιεί ένα μικρό, φθηνό και απλό πρότυπο μηχάνημα αιμοκάθαρσης που απομακρύνει εξωσωματικά τα Β-αμυλοειδή χωρίς να επιτρέπει στο βήτα-αμυλοειδές να επιστρέψει στο σώμα ενός υποκειμένου και χωρίς να χρειάζεται να εκτιμήσει λεπτομερώς την απόδοση και τα χαρακτηριστικά μιας μεμβράνης αιμοκάθαρσης και χωρίς να τίθεται σε κίνδυνο η κατάσταση της υγείας του υποκειμένου.The present invention provides a safe, reliable and economical process for preparing an improved dialysis fluid preparation, which is effective for in vitro treatment, by a blood filtration method, a Beta-Amyloid-associated condition in a subject, which method comprises preparing a composition comprising a KLVFF peptide or a variant thereof as a capture and binding agent and a carrier, and mixing said composition with a dialysis solution. The method uses a small, inexpensive and simple standard dialysis machine that removes B-amyloids extracorporeally without allowing beta-amyloid to return to a subject's body without having to evaluate in detail the performance and characteristics of a dialysis membrane and without the state of health of the subject is endangered.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261638672P | 2012-04-26 | 2012-04-26 | |
PCT/PH2013/000005 WO2013162387A1 (en) | 2012-04-26 | 2013-01-30 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof |
PH12013000037 | 2013-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1120610T1 true CY1120610T1 (en) | 2019-12-11 |
Family
ID=68771305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY181100895T CY1120610T1 (en) | 2012-04-26 | 2018-08-28 | NEW COMPOSITION FOR THE EXTRAORDINARY REDUCTION OF BETA-AMYLOIDS AND ITS PRODUCTION PROCESS |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1120610T1 (en) |
-
2018
- 2018-08-28 CY CY181100895T patent/CY1120610T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201990043A1 (en) | ANTIBACTERIAL CONNECTIONS | |
PH12015501558A1 (en) | Human antibodies to respiratory syncytial virus f protein and methods of use thereof | |
EA201790377A1 (en) | ANTIBODIES TO GLUCAGON AND THEIR APPLICATIONS | |
EA201890204A1 (en) | ANTIBACTERIAL CONNECTIONS | |
EA201591427A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
BR112016015140A2 (en) | tandem-fab immunoglobulin and its uses | |
EA201590343A1 (en) | ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES | |
UA118332C2 (en) | Cs27l antigen binding proteins | |
EA201590667A1 (en) | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
EA201591166A1 (en) | AUTOTAXIN INHIBITORS | |
EA201691060A1 (en) | TRANSTIRETINAL (TTR) AMYLOIDOSIS THERAPY WITH ANTIBODIES AND ALSO ANTIBODIES RECEIVED FROM HUMAN FOR THE INDICATED THERAPY | |
EA201992133A1 (en) | PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS | |
EA202193044A2 (en) | METHODS OF TREATMENT OF TAUPATHY | |
EA201591430A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
EA201590890A1 (en) | DERIVATIVES 5-FLUOR-N- (PYRIDIN-2-IL) PYRIDIN-2-AMINE CONTAINING A SULPHOXIMINE GROUP | |
EA201591426A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
EA201270018A1 (en) | Opsync ligands, compositions and methods of use | |
BR112013010857A2 (en) | double domain variable imonoglubulines and their uses | |
BR112012032778A2 (en) | "multispecific and multivalent proteins" | |
EA201591432A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
EA201500383A1 (en) | DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS | |
EA201492040A1 (en) | BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION | |
EA201992707A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION | |
TR201909447T4 (en) | Aramkol salts. | |
EA201692279A1 (en) | METHOD FOR REDUCING IMMUNOGENIC PROTEIN AND PEPTIDE |